Non-small Cell Lung Carcinoma
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-09-14Clinical Trial Update: Feasibility of Cetuximab Associated With Concomitant Radio-Chemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer [Phase 2]
Phase 2 trial assessing feasibility of cetuximab with concomitant radiotherapy and chemotherapy in locally advanced non-small cell lung canc…
-
CLINICAL_TRIALS trial_result · 2017-09-13Clinical Trial Update: Non-small Cell Lung Cancer Study US75 (Z-PACT) [Phase 3]
Phase 3 clinical trial update for a non-small cell lung cancer study (US75/Z-PACT) completed.
-
CLINICAL_TRIALS trial_result · 2017-07-07Clinical Trial Update: Study of Pembrolizumab (MK-3475) Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024) [Phase 3]
Phase 3 trial comparing pembrolizumab to platinum-based chemotherapy in metastatic non-small cell lung cancer has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2017-06-29Clinical Trial Update: Safety and Efficacy Clinical Study of SNS-595 for Second-Line Therapy in Patients With Advanced NSCLC [Phase 2]
Phase 2 clinical trial update for SNS-595 as second-line therapy in advanced non-small cell lung cancer (NSCLC) has completed with results p…
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: Phase I, Study in Chinese NSCLC Patients [Phase 1]
Phase I trial in Chinese patients with EGFR-mutated non-small cell lung carcinoma completed, with results posted in 2017.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-11-21Clinical Trial Update: Vorinostat and Bortezomib as Third-line Treatment in Advanced Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating vorinostat and bortezomib as third-line therapy in advanced non-small cell lung cancer has completed with results p…
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Trial of Dasatinib in Patients With Advanced Cancers Harboring DDR2 Mutation or Inactivating B-RAF Mutation [Phase 2]
Phase 2 trial of dasatinib in advanced cancers with DDR2 or B-RAF mutations was terminated; results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2014-11-07Clinical Trial Update: OSI-774 in African American Patients With Advanced and Previously Treated Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial update of OSI-774 in African American patients with advanced and previously treated non-small cell lung cancer.